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Abstract
Objectives: To examine the role of medication use and other factors in 
predicting activity restriction due to a fear of falling (AR/FF). Methods: Older 
adults were assessed twice with the interRAI Community Health Assess-
ment and the Berg Balance Scale (BBS). The main outcome was limiting going 
outdoors due to an AR/FF. Medications were recorded by trained asses-
sors. Results: Participants (n = 441) had a mean age of 80.3 (SD = 7.1) years, 
most were aged 65+ (96.8%) and 29.3% reported activity restriction. Taking 
nervous system active or cardiovascular medications was associated with 
AR/FF. In a multivariate model, the main predictors were having 3+ comor-
bid health conditions, lower (i.e., worse) scores on the BBS, having difficulty 
with climbing stairs, and having a visual impairment. Discussion: Modifiable 
risk factors, related to functional impairments, such as difficulties with bal-
ance and vision, appear to be more important predictors than medications.
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It is widely understood that falls in older adults (65+) have serious implica-
tions for their health, mortality, and quality of life. Having had a fall often 
leads to a fear of falling (FF) in this population (Scheffer, Schuurmans, van 
Dijk, van der Hooft, & de Rooij, 2008). One potential consequence of a FF is 
activity restriction. Estimates of the prevalence of activity restriction due to a 
FF (hereafter referred to as “AR/FF”) range from 19% to 60% (Curcio, 
Gomez, & Reyes-Ortiz, 2009; Deshpande et al., 2008b; Fletcher & Hirdes, 
2004; Fletcher, Guthrie, Berg, & Hirdes, 2010; Jang, Cho, Oh, Lee, & Baik, 2007; 
Kempen, van Haastregt, McKee, Delbaere, & Zijlstra, 2009; Murphy, Williams, 
& Gill, 2002; Wilson et al., 2005; Zijlstra et al., 2007). This has important 
implications as AR/FF is related to lower levels of performance in activities 
of daily living (ADLs; Curcio et al., 2009; Deshpande et al., 2008b), reduced 
mobility (Deshpande et al., 2008b), and falls (Curcio et al., 2009).
Several studies have examined different types of medications and the risk of 
falls in community-dwelling older adults. For example, the risk is increased 
among those taking benzodiazepines (BZDs; Ensrud et al., 2002; Leipzig, 
Cumming, & Tinetti, 1999; Souchet, Lapeyre-Mestre, & Montastruc, 2005), 
antidepressants (Kelly et al., 2003; Leipzig et al., 1999; Souchet et al., 2005), 
cardiac medications (Souchet et al., 2005), narcotics (Ensrud et al., 2002; Kelly 
et al., 2003), and anticonvulsants (Ensrud et al., 2002; Kelly et al., 2003).
Some medications have also been linked to an increased risk of fracture 
and other injuries. In particular, BZDs have been found to slightly increase 
the risk of femur fracture among nursing home residents(Sgadari et al., 2000) 
and to elevate the risk of various types of injuries, including fractures, sprains, 
strains, and contusions, among veterans attending an outpatient medical 
clinic (French, Campbell, Spehar, & Angarn, 2005). Some research has also 
shown that older adults (aged 50+) taking a particular type of antidepressant, 
namely selective serotonin reuptake inhibitors (SSRIs), had twice the risk of 
experiencing a fragility fracture (e.g., fracture caused by minor trauma such 
as falling from a bed or a chair; Richards et al., 2007).
The literature linking falls and medication use has been limited by several 
methodological issues. For example, a recent systematic review identified 
that many studies have failed to explicitly outline how they define a “fall,” 
medications have not been categorized using a standardized therapeutic clas-
sification system (e.g., Anatomical Therapeutic Chemical system developed 
by World Health Organization) and several confounding variables, such as 
 at WILFRID LAURIER UNIV on October 26, 2011jah.sagepub.comDownloaded from 
Guthrie et al. 3
age and sex, have been inadequately adjusted for in multivariate analyses 
(Hartikainen, Lonnroos, & Louhivuori, 2007). Furthermore, some studies 
have failed to consider confounding by indication, which assesses the degree 
to which the risk of falls is related to underlying comorbid conditions as 
opposed to the therapeutic drug regimen (Daal & van Lieshout, 2005). The 
presence of certain chronic health conditions may be more important than 
medication use as a risk for falling (Lawlor, Patel, & Ebrahim, 2003).
Although it is well understood that certain medications increase the risk of 
falls, little is known about the use of medications and AR/FF. From a clinical 
point of view, it is conceivable that persons taking certain medications and 
experiencing more falls and/or symptoms that put them at risk of falling (e.g., 
dizziness) may limit their activities due to an AR/FF. Polypharmacy has been 
shown as an important risk factor (Curcio et al., 2009; Jang et al., 2007) and 
in one study; the risk was increased among those taking drugs to treat depres-
sion or anxiety (Austin, Devine, Dick, Prince, & Bruce, 2007). It is not well 
understood whether certain classes of medications are independently associ-
ated with an increased risk of AR/FF and how previous falls and other risk 
factors for falling influence this relationship.
The current article attempts to address several of the limitations in the cur-
rent literature by assessing the unique contribution of different classes of 
medications, while taking into account important confounding variables, 
including the presence of various chronic health conditions, as they relate to 
AR/FF. We hypothesized that certain classes of medications, known to 
increase the risk of falling (e.g., BZDs, antidepressants), would increase the 
risk of AR/FF in this sample of community-dwelling older adults after con-
trolling for other established risk factors for falling.
Method
The current project represents secondary analysis of data collected during 
five independent intervention studies on falls among older adults in the 
community. The methods have been described elsewhere (Fletcher, Berg, 
Dalby, & Hirdes, 2009; Fletcher et al., 2010). Briefly, each of the sites were 
individually funded, set their own inclusion criteria, and determined the 
data collection procedures and instruments to be used. However, as part of 
the current project, each site was also required to collect additional assess-
ments for each participant. The research teams from each site oversaw 
subject recruitment and all data submitted were stripped of unique identifi-
ers. As such, additional ethics approval was not required for the analyses of 
combined data sets.
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Five sites recruited older adults (typically those aged 65+) for a falls inter-
vention program. The nature of each program varied in intensity and 
approach. Some projects simply provided information to study participants 
whereas others offered a more intense and multifactoral intervention.
Research assistants (RAs) within each site were trained to complete an 
early version of the interRAI Community Health Assessment (CHA). This 
assessment tool was designed by interRAI (www.interrai.org), a not-for-profit 
research network, of more than 30 countries, whose focus is on the develop-
ment and testing of assessment systems to improve the quality of life and 
delivery of services for vulnerable populations including older persons and 
persons with disabilities. The interRAI CHA captures basic demographic 
background as well as detailed information across 13 domains, including 
activities of daily (ADLs), instrumental ADLs, social functioning, mental 
health, and pain. In Ontario, interRAI assessment tools have been mandated 
by the provincial government in the home care sector, in complex continuing 
care facilities and phased implementation is currently ongoing in all long-
term care homes.
Training in the use of the interRAI CHA was led by an experienced clini-
cal educator affiliated with the University of Waterloo. The RAs were given 
detailed instructions for coding of each item as outlined in the training man-
ual (Morris et al., 2006). Each participant was assessed twice, both prior to 
(baseline assessment) and following (reassessment) the site-specific inter-
vention. The average time between assessments was 249.7 days (SD = 138.4).
Measures
The interRAI CHA contains approximately 150 items that represent a subset 
of the larger interRAI Home Care Instrument (Morris et al., 1999). The main 
dependent variable, activity restriction due to an AR/FF, was captured with a 
single dichotomous item: “Person limits going outdoors due to a fear of fall-
ing (e.g., stopped using bus, goes out only with others”; Morris et al., 2006).
Although not included in the core items on the interRAI CHA, two other 
questions were added and were taken verbatim from items include in the 
interRAI Home Care Instrument. One question assessed the person’s ability 
to walk a quarter of a mile (about three blocks) and was coded from 0 (no 
difficulty) to 3 (completely unable). The second question rated their ability 
to navigate stairs and was coded as 0 (up and down stair without help), 1 (up 
and down stairs with help) or 2 (did not go up and down stairs).
A number of health subscales can be generated from the interRAI CHA. 
The Cognitive Performance Scale (CPS; Morris et al., 1994) ranges from 0 to 
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6 (higher scores indicate greater cognitive impairment) and has been vali-
dated against the Mini-Mental State Examination (Hartmaier et al., 1995). 
The Depression Rating Scale (DRS) assesses depressive symptoms and a 
score of three or higher is typically used as a cut-off predictive of psychiatrist 
ratings and clinical thresholds used with the Hamilton and Cornell Scales 
(Martin et al., 2008). The Activities of Daily Living Self-performance 
Hierarchy Scale (ADL SHS) uses four ADL items and rates individuals 
from 0 to 6, with a higher score indicating a greater need for assistance. Its 
reliability and validity have been previously established (Morris, Fries, & 
Morris, 1999). The Changes in Health End-stage Disease Signs and Symptoms 
(CHESS) scale was developed to detect health instability. Higher scores on 
the CHESS are associated with reduced survival over time (Armstrong, 
Stolee, Hirdes, & Poss, 2010; Hirdes, Frijters, & Teare, 2003). The Pain 
Scale uses two items to create a score that ranges from 0 (no pain) to 3 (severe 
daily pain) and has been shown to be highly predictive of pain on the Visual 
Analogue Scale in nursing home residents (Fries, Simon, Morris, Flodstrom, 
& Bookstein, 2001).
Each person was also assessed with the Berg Balance Scale. This scale 
includes 14 items that represent typical daily activities (e.g., sitting, standing) 
and generates a score from 0 to 56, with a higher score indicating better per-
formance. The scale has been previously validated in older individuals (Muir, 
Berg, Chesworth, & Speechley, 2008).
Assessors recorded all medications taken within the previous week, 
including both prescription and over-the-counter preparations. The assessors 
were trained to use all information available to them, including reviewing the 
labels on pill bottles, asking the person or family member directly, and/or 
contacting the family physician or pharmacist as needed. The drug order date 
was not captured. Medications considered as risk factors for falling or AR/FF 
was coded into four mutually exclusive therapeutic classes: (a) nervous sys-
tem active medications (e.g., benzodiazepines, antidepressants); (b) analge-
sics (e.g., nonopioid analgesics, including nonsteroidal antiinflammatory 
drugs, opioid analgesics); (c) cardiovascular medications (e.g., anticoagu-
lants, antihypertensives); and (d) diuretics. These classes were based on a 
modification to the American Hospital Formulary System (American Society 
of Health-System Pharmacists, 2006) and coding of each drug was led by a 
physician (EW).
Participants taking at least one of the medications in a given category 
were included in that category (i.e., presence vs. absence of taking any drug 
within the category) regardless of the frequency or dose. The only exception 
was in the case of low dose aspirin (81 mg per day) which was coded as an 
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anticoagulant (Category 3), and higher doses of aspirin, were included with 
analgesics (Category 2; nonopioid analgesic).
Analysis
Because of concerns about data quality, one site (n = 150) was removed prior 
to data analysis. The participants from this site were significantly more likely 
to be female (92.4% vs. 67.1%; p < .0001), to be divorced/widowed/never 
married (17.4% vs. 7.4%; p = .003), were less likely to report AR/FF 
(12.9% vs. 30.1%; p < .0001), and were significantly younger (mean age: 
70.4 years vs. 79.5; p < .0001). The final sample included 571 individuals, 
of whom, 441 (77.2%) participants had nonmissing data for the main outcome 
on reassessment. The lack of outcome data on reassessment reflects the vol-
untary nature of the study and the fact that we had virtually no control over 
data collection and follow-up with study participants.
All explanatory variables and potential confounders were measured using 
the baseline assessment. The Pearson’s chi-square test was used for categor-
ical variables and the Student t-test for continuous variables to assess the 
bivariate (unadjusted) relationship between outcome variables, explanatory 
variables, and potential confounders. An alpha level of .05 (two-tailed) was 
used in all cases.
Multivariate logistic regression models were created to examine the influence 
of medication use after controlling for other potential explanatory variables. 
Variables considered as potential covariates included: age, sex, marital status, 
site, number and specific type of comorbid health conditions, Berg Balance 
Scale score, and scores on each of the CPS, DRS, ADL SHS, CHESS Scale, 
and Pain Scale, stair climbing, previous falls, poor self-rated health, dizzi-
ness, presence of environmental home hazards, vision impairment, ability to 
walk a quarter of a mile, loneliness, distress related to a decline in participa-
tion in social activities, the presence of any psychiatric diagnosis (single 
item), and each therapeutic class of drug. Specific subclasses of drugs (e.g., 
benzodiazepines) were only included if at least 10% of participants were taking 
these medications.
A variety of modeling techniques were used, including forward selection, 
backward elimination, and stepwise methods, to rule out order effects prior to 
specification of the final model. Only the covariates that were significantly 
related to the dependent measure (p < .05) were examined in the multivariate 
models. Once the final multivariate model was specified, those candidate 
variables which had been significant at the bivariate level were then individu-
ally entered into the final model in order to assess whether they would remain 
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significant or change the contribution of the existing covariates. This was 
done to eliminate the possibility of covariates being dropped from the model 
due to order effects in the stepwise procedures.
Logit plots were created for all continuous and ordinal variables and indi-
cated that four covariates should be entered as discrete variables, namely, 
marital status, age, ADL SHS and number of health conditions. In the final 
model, all two-way interactions were considered but none were statistically 
significant. Multicollinearity in the final model was assessed using the vari-
ance inflation factor (VIF), whereby a score of 2.5 or higher was considered 
indicative of multicollinearity (Allison, 2001). All analyses were completed 
using SAS version 9.1 (SAS Institute Inc., 2001).
Results
Participants had a mean age of 80.3 (SD = 7.1) years, most were female 
(66.4%) and just more than half (50.1%) were married. Nearly 75% of partici-
pants were taking four or more different medications, 43.5% had an unsteady 
gait, and 31.2% limited going outdoors due to an AR/FF. Sites 3 and 4 recruited 
the majority of clients (64.4%; Table 1).
Participants with AR/FF were significantly (p < .05 in all cases) more 
likely to be taking multiple medications, to have three or more coexisting 
health conditions, to be experiencing unsteady gait, to have had two or more 
recent falls, to have a vision impairment, to being showing signs or symp-
toms of depression, to have ADL impairments, to have moderate to severe 
health instability, and to have moderate to severe pain. The study site was 
also significantly related to AR/FF (p < .0001) with the prevalence ranging 
from 2.3 to 41.1% (Table 1).
The most prevalent type of medication used was cardiovascular medica-
tions (66.9%), followed by analgesics (51.7%), nervous system active (NSA) 
medications (30.8%) and last, diuretics (11.1%; Table 2). Individuals who 
reported AR/FF were significantly more likely to be taking any NSA medica-
tion (p = .003) or any cardiovascular medication (p = .001). Individuals who 
were taking any type of NSA medication, any type of cardiovascular drug or 
any type of analgesic had a significantly lower (i.e., worse performance) 
score on the Berg Balance Scale (p < .05 in all cases). Across the four classes 
of medications, age was a significant factor only for cardiovascular medica-
tions, such that those taking any of these drugs were significantly older than 
those who were not (81.0 years vs. 79.0; p < .001). Among those taking any 
NSA medications, they were significantly more likely to be female (75.7% vs. 
62.6%; p = .007). Gender was nonsignificant across the other drug classes. 
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Table 1. Explanatory Variables and Demographic Characteristics of Study 
Participants (n = 441) by Activity Restriction Due to a Fear of Falling
% (n)  
 
Total sample 
(n = 441)
No activity 
restriction 
(n = 312)
Activity 
restriction  
(n = 129) p value
Age
 Mean (SD) 80.3 (7.1) 79.3 (7.1) 82.8 (6.3)  
 18-64 3.2 (14) 4.2 (13) 0.8 (1) .001
 65-74 14.1 (62) 16.0 (50) 9.3 (12)  
 75-84 59.6 (263) 61.2 (191) 55.8 (72)  
 85+ 23.1 (102) 18.6 (58) 34.1 (44)  
Female 66.7 (294) 61.2 (191) 79.8 (103) .0002
Marital status
 Married 49.7 (219) 58.0 (181) 29.5 (38) <.0001
 Widowed 42.6 (188) 33.3 (104) 65.1 (84)  
 Other 7.7 (34) 8.7 (27) 5.4 (7)  
Site
 One 15.0 (66) 7.1 (22) 34.1 (44) <.0001
 Two 8.6 (38) 11.2 (35) 2.3 (3)  
 Three 39.2 (173) 49.4 (154) 14.7 (19)  
 Four 25.2 (111) 18.6 (58) 41.1 (53)  
 Five 12.0 (53) 13.8 (43) 7.8 (10)  
Number of prescription medications
 0-3 25.4 (112) 29.2 (91) 16.3 (21) .005
 4+ 74.60 (329) 70.83 (221) 83.72 (108)  
Number of health conditions
 0-2 50.1 (221) 59.9 (187) 26.4 (34) <.0001
 3+ 49.9 (220) 40.1 (125) 73.6 (95)  
Unsteady gait 43.5 (191) 30.9 (96) 74.2 (95) <.0001
Number of falls
 0 70.0 (308) 74.6 (232) 58.9 (76) .0002
 1 17.7 (78) 17.0 (53) 19.4 (25)  
 2+ 12.3 (54) 8.4 (26) 21.7 (28)  
Vision
 Adequate 80.7 (355) 87.5 (272) 64.3 (83) <.0001
 Impaired 19.3 (85) 12.5 (39) 35.7 (46)  
(continued)
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% (n)  
 
Total sample 
(n = 441)
No activity 
restriction 
(n = 312)
Activity 
restriction  
(n = 129) p value
Stair climbing
 Manages stairs without help 57.0 (250) 71.9 (223) 20.9 (27) <.0001
 Manages stairs with help 20.7 (91) 12.3 (38) 41.1 (53)  
 Did not do stairs 22.3 (98) 15.8 (49) 38.0 (49)  
Presence of at least one home 
hazard
21.7 (94) 20.33 (62) 25.00 (32) .28
Distress related to a decline in social activities
 Not distressed by decline 87.5 (385) 92.3 (287) 76.0 (98) <0.0001
  Person is distressed by  
  decline
12.5 (55) 7.7 (24) 24.0 (31)  
Berg Balance Scale Score 
Mean (SD)
45.6 (11.9) 49.6 (8.0) 36.1 (14.1) <0.0001
CPS Score
No impairment 95.9 (419) 97.4 (300) 92.3 (119) .013
At least mild impairment 4.1 (18) 2.6 (8) 7.8 (10)  
DRS Score
  No signs/symptoms of  
  depression
86.9 (375) 89.8 (274) 79.5 (101) 0.0039
  Signs/symptoms of  
  depression
13.2 (57) 10.2 (31) 20.5 (26)  
Activities of daily living SHS
 No impairment 97.0 (426) 98.7 (306) 93.0 (120) .0014
 At least mild impairment 3.0 (13) 1.3 (4) 7.0 (9)  
CHESS Score
  None or mild health  
  instability
79.9 (325) 86.3 (251) 63.8 (74) <.0001
  Moderate to severe health  
  instability
20.2 (82) 13.8 (40) 36.2 (42)  
Pain Scale Score  
 None or mild pain 56.6 (249) 64.3 (200) 38.0 (49) <.0001
 Moderate to severe pain 43.4 (191) 35.7 (111) 62.0 (80)  
Table 1. (continued)
Participants taking any NSA drug were also significantly more likely to have 
multiple falls in the previous 90 days (17.7% vs. 9.9%; p = .0006). Previous 
falls was not related to the other classes of medications (data not shown).
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Table 2. Unadjusted Relationship of Therapeutic Drug Classes to Activity 
Restriction Due to a Fear of Falling
% (n)
 
 
Total  
(n = 441)
No activity 
restriction 
(n = 312)
Activity 
restriction 
(n = 129) p value
Taking any nervous system 
active (NSA) medication
30.8 (136) 26.6 (83) 41.1 (53) .0027
Subgroups of NSA medications
 Benzodiazepines 11.1 (49) 9.6 (30) 14.7 (19) .12
 Antidepressants 18.8 (83) 13.8 (43) 31.0 (40) <.0001
 Anticonvulsants 4.3 (19) 4.8 (15) 3.1 (4) .42
 Sedatives/hypnotics 4.3 (19) 3.5 (11) 6.2 (8) .21
 Antipsychotics 1.1 (5) 1.3 (4) 0.8 (1) .65
Taking any analgesic medication 51.7 (228) 49.0 (153) 58.1 (75) .08
Subgroups of analgesic medications
 Nonopioid analgesics 49.0 (216) 47.1 (147) 53.5 (69) .22
 Opioid analgesics 7.7 (34) 6.1 (19) 11.6 (15) .05
Taking any cardiovascular (CV) 
medication
66.9 (295) 62.2 (194) 78.3 (101) .001
Subgroups of CV medications
 Cardiac drugs 32.4 (143) 29.8 (93) 38.8 (50) .07
 Antiarrhythmic 11.6 (51) 10.6 (33) 14.0 (18) .31
 Anticoagulants 8.6 (38) 7.7 (24) 10.9 (14) .28
 Antilipemic 24.7 (109) 24.7 (77) 24.8 (32) .98
 Antihypertensive 31.3 (138) 29.8 (93) 34.9 (45) .30
 Vasodilating drugs 9.1 (40) 6.4 (20) 15.5 (20) .003
Diuretics 11.1 (49) 9.6 (30) 14.7 (19) .12
In a preliminary model (Model 1 in Table 3), several demographic charac-
teristics were not significant predictors of AR/FF, including age, sex, and 
marital status. The same was found for the number of previous falls as well 
as each of the four therapeutic classes of medications. After adjusting for these 
variables, the covariates that were statistically important included: having 
three or more comorbid health conditions (OR = 1.78), needing assistance 
with stairs (OR = 3.52), the presence of a visual impairment (1.87), and hav-
ing a lower score on the Berg Balance Scale (0.73). In the final multivariate 
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Table 3. Multivariate Models Predicting Activity Restriction Due to a Fear of Falling
Model 1a Model 2b
Characteristics
Estimate (Std. 
error)
Adjusted odds 
ratio (95% CI)
Estimate 
(Std. Error)
Adjusted odds 
ratio (95% CI)
Age (10 year increase) 0.028 [0.02] 1.32 [0.82,2.09]  
Female 0.30 [0.33] 1.35 [0.71,2.59]  
Marital status  
 Married Ref Ref  
 Widowed 0.34 [0.31] 1.40 [0.76,2.59]  
  Never married,  
  divorced, other
−0.60 [0.57] 0.55 [0.18,1.67]  
Number of falls  
 0 Ref Ref  
 1 0.07 [0.35] 1.08 [0.55,2.13]  
 2+ 0.15 [0.38] 1.16 [0.55,2.58]  
Taking any nervous system active [NSA] medication
 No Ref Ref  
 Yes 0.10 [0.33] 1.11 [0.58,2.11]  
Taking any analgesic medication
 No Ref Ref  
 Yes 0.12 [0.27] 1.12 [0.66,1.92]  
Taking any cardiovascular [CV] medication
 No Ref Ref  
 Yes 0.42 [0.31] 1.52 [0.83,2.78]  
Taking any diuretic
 No Ref Ref  
 Yes 0.39 [0.45] 1.47 [0.61,3.57]  
Number of comorbid health conditions
 Zero to two Ref Ref Ref Ref
 Three or more 0.58 [0.29] 1.78 [1.01,3.13] 0.74 [0.28] 2.09 [1.22,3.59]
Ability to climb stairs
 No assistance required Ref Ref Ref Ref
 Stairs with assistance 1.26 [0.36] 3.52 [1.73,7.18] 1.38 [0.34] 3.96 [2.04,7.72]
 Did not climb stairs 0.79 [0.37] 2.21 [1.07,4.58] 1.03 [0.35] 2.80 [1.18,3.84]
Presence of any visual 
impairment
0.64 [0.32] 1.87 [1.0,3.50] 0.75 [0.3] 2.04 [1.11,3.76]
Five-point change on 
Berg Balance Scale
−0.06 [0.01] 0.73 [0.63,0.83] −0.07 [0.01] 0.71 [0.63,0.82]
a. Each adjusted OR was adjusted for the 11 other variables in the model; c statistic = .86
b. Parsimonious final model including the four variables that remained statistically significant  
(p < .05); c statistic = .85.
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model, which included only these four significant covariates (Model 2), the 
odds ratios remained quite stable when compared to Model 1. The Hosmer 
and Lemeshow goodness-of-fit chi-square was not significant (p = .73), sug-
gesting an adequate fit of the model (Hosmer & Lemeshow, 2000). Furthermore, 
the variance inflation factor was less than 1.75 in all cases, suggesting that 
multicollinearity was not present.
Discussion
In this project, 29% of adults limited their outdoor activities due to a fear of 
falling. This is consistent with other studies among community-dwelling 
seniors (Fletcher et al., 2010; Jang et al., 2007; Murphy et al., 2002; Zijlstra 
et al., 2007) and those receiving home care services (Fletcher & Hirdes, 
2004), but significantly lower than that reported in two previous studies 
(Curcio et al., 2009; Deshpande et al., 2008b). This is likely a reflection of 
the definition of activity restriction. This article used a more global defini-
tion of outdoor activities captured with a single question, whereas other 
research, reporting a higher prevalence, measured activity restriction across 
a number of specific activities (Deshpande et al., 2008b).
A key objective of this project was to assess the role of specific medica-
tions in predicting AR/FF. At the bivariate level, both central nervous system 
active (NSA) drugs and cardiovascular medications were important predic-
tors. In addition, NSA drugs were related to an increased number of falls and 
three classes of medications, namely NSA drugs, cardiovascular drugs, and 
analgesics, were associated with worse performance on the Berg Balance 
Scale. Other research has shown an important role for antipsychotics (Fletcher 
& Hirdes, 2004) or for other NSA drugs to treat depression or anxiety (Austin 
et al., 2007) in the risk of AR/FF. However, after adjusting for other covari-
ates, these classes of medications were nonsignificant. This may be due to the 
sample size of the study and the limited number of participants who were 
taking specific types of medications, such as antipsychotics. These results 
may also reflect the fact that medications, although associated with AR/FF, 
may have a more indirect effect through changes to one’s risk of falling (e.g., 
through symptoms such as dizziness) that are difficult to detect without 
extensive longitudinal data that better map out the sequential changes that 
occur following the implementation of certain medications.
Our study confirms the importance of visual impairments (Curcio et al., 
2009; Fletcher & Hirdes, 2004; Murphy et al., 2002) and difficulties with 
balance (Deshpande et al., 2008b) as important independent predictors of AR/
FF. Requiring assistance in navigating stairs was also an important predictor 
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and has not been reported in other studies. Having multiple coexisting health 
conditions was also important, and has been infrequently shown to be a risk 
factor in the literature (Murphy et al., 2002).
Depression has also been previously reported as a predictor of this 
outcome (Austin et al., 2007; Curcio et al., 2009; Deshpande et al., 2008a; 
Murphy et al., 2002). The current analysis also found, at the bivariate level, 
an increased likelihood of AR/FF among clients with signs or symptoms of 
depression and among those taking antidepressant medications. The presence 
of symptoms of depression, however, was not important in the final multi-
variate model. The single item on the interRAI CHA indicates the presence 
of any psychiatric diagnosis, so we were unable to examine the diagnosis of 
depression on its own. However, given the high prevalence of the use of anti-
depressants (18% in our sample), it is likely that depression was the main 
psychiatric diagnosis.
A decline in social activities, with perceived distress on the part of the 
person, was associated with the main outcome variable. Although measured 
somewhat differently, other studies have also found that measure of social 
isolation, such as living alone (Austin et al., 2007) or being alone for long 
periods of time in a day (Fletcher & Hirdes, 2004) are associated with AR/FF. 
Given the fact that depression appears to be related to activity restriction, this 
suggests that AR/FF may be a key indicator of more global restrictions in 
one’s activities. Activity restriction may reflect a process whereby older 
adults become more socially isolated and in turn, begin experiencing signs of 
depression. Alternatively, it may be that depression, and subsequent lack of 
motivation and/or lack of confidence, may lead to activity restriction.
One clear departure from the current evidence is the lack of an indepen-
dent association between AR/FF and previous falls. Multiple studies have 
shown falls to be an important risk factor (Austin et al., 2007; Curcio et al., 
2009; Fletcher & Hirdes, 2004; Fletcher et al., 2010; Zijlstra et al., 2007) and 
only one did not (Jang et al., 2007). In the study by Murphy et al. (2002), only 
injurious falls were associated with activity restriction. We did, however, 
show falls to be important at the bivariate level but the item did not remain 
significant after adjusting for factors such as difficulties with navigating stairs 
and difficulties with balance.
Neither age nor sex was important, after adjusting for other important 
covariates. There are mixed findings in the current literature with some stud-
ies reporting older age as important (Kempen et al., 2009; Murphy et al., 
2002; Zijlstra et al., 2007) and others, reporting a non-significant relationship 
(Austin et al., 2007; Jang et al., 2007). Being female has typically been seen 
to increase the risk of AR/FF (Fletcher & Hirdes, 2004; Kempen et al., 2009; 
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Murphy et al., 2002; Zijlstra et al., 2007). However, in at least one study, 
adjusting for AR/FF removed the effect of gender on activity restriction, sug-
gesting that fear was the key factor as opposed to being female per se 
(Deshpande et al., 2008a).
One limitation to this study is the fact that the participants represent a 
nonrandom convenience sample of volunteers. As such, it is likely that their 
risk profile, for falling and AR/FF, is different from the larger population of 
seniors in Ontario. This could, at least in part, explain the lack of consistency 
between this project and previous research, as it relates to risk factors such as 
age, sex, and previous falls.
Furthermore, we have chosen activity restriction, a behavioral outcome, 
as the main dependent variable. Although we can explore the relationship 
between activity restriction and a host of clinical and functional risk factors, 
the cross-sectional nature of the data do not allow for a full exploration of 
how medication use may lead to changes in symptoms related to falls, such 
as dizziness or unsteady gait, which may increase the risk of falls which, if a 
fall takes place, may then result in activity restriction. As such, the current 
findings cannot easily shed light on the causal pathway linking certain medi-
cations, and the diagnoses for which they were prescribed, with changes in 
psychosocial and behavioral outcomes. Future research using a prospective 
cohort design would be better able to address these limitations.
A longitudinal design would also be able to address the fact that the inter-
RAI CHA does not include the date the medication was ordered. The cross-
sectional nature of this study makes it difficult to clearly determine cause and 
effect when looking at medication use. Given that the interRAI CHA is 
scheduled to be mandated for all community support services in Ontario, this 
type of analysis may soon be feasible.
The use of the interRAI CHA represents a significant strength of this proj-
ect given its multidimensional nature and the fact that it will soon be the 
assessment of choice across the province. With data such as these, we have 
been able to study a broad range of covariates related not only to demo-
graphic characteristics but also to physical performance, functional status, 
and psychosocial factors. As has been demonstrated, understanding AR/FF is 
a complex issue that cannot be explained simply by looking at physical per-
formance in areas such as vision, walking, or gait. There appears to be a 
psychosocial component related to social isolation and depression that should 
be explored further in a more rigorous study that includes a larger sample size 
than in the current project.
For clinicians, and those serving older adults in the community, under-
standing what contributes to activity restriction can have a positive effect 
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on the quality of life and health of their clients. As we have shown, certain 
classes of medications (e.g., nervous system active and cardiovascular 
medications) are related, on their own, to AR/FF. However, there are other 
modifiable risk factors (e.g., impaired vision, difficulties with balance) that 
appear to be more important in predicting activity restriction due to an AR/
FF than medications. By recognizing how these modifiable factors may lead 
to activity restriction, which in turn may result in feelings of social isolation 
or depression, there is an important opportunity to identify seniors at risk 
early in this process. Early identification can ideally result in timely inter-
vention. Given the importance of balance as a risk factor, prevention efforts 
should incorporate opportunities to increase capacity in areas such as bal-
ance, strength, and endurance.
If the appropriate programs and interventions are put into place that enable 
older adults to be more active, improve their balance, be less fearful and be 
engaged socially, there is the strong potential to reduce the likelihood of neg-
ative outcomes such as falling or developing an AR/FF.
Acknowledgments
The authors gratefully acknowledge Mr. Jeremiah Beggs for assistance with data 
analysis.
Declaration of Conflicting Interests
The authors declared no potential conflicts of interest with respect to the research, 
authorship, and/or publication of this article.
Funding
The authors disclosed receipt of the following financial support for the research, 
authorship, and/or publication of this article: This study was supported by the finan-
cial contribution from Veterans Affairs Canada- Falls Prevention Initiative, Health 
Canada. The views expressed herein do not necessarily represent the official pol-
icy of Health Canada or Veterans Affairs Canada. Dr. Hirdes’ work was supported 
through the Ontario Home Care Research and Knowledge Exchange Chair award 
from the Ontario Ministry of Health and Long-Term Care.
References
Allison, P. D. (2001). Logistic regression using the SAS system: Theory and applica-
tion. New York, NY: John Wiley.
American Society of Health-System Pharmacists. (2006). AHFS: Drug information. 
Bethesda, MD: American Society of Health-System Pharmacists.
 at WILFRID LAURIER UNIV on October 26, 2011jah.sagepub.comDownloaded from 
16  Journal of Aging and Health XX(X)
Armstrong, J. J., Stolee, P., Hirdes, J. P., & Poss, J. W. (2010). Examining three 
frailty conceptualizations in their ability to predict negative outcomes for home-
care clients. Age and Ageing, 39, 755-758.
Austin, N., Devine, A., Dick, I., Prince, R., & Bruce, D. (2007). Fear of falling 
in older women: A longitudinal study of incidence, persistence, and predictors. 
Journal of American Geriatrics Society, 55, 1598-1603.
Curcio, C. L., Gomez, F., & Reyes-Ortiz, C. A. (2009). Activity restriction related to 
fear of falling among older people in the Colombian Andes mountains: Are func-
tional or psychosocial risk factors more important? Journal of Aging and Health, 
21, 460-479.
Daal, J. O., & van Lieshout, J. J. (2005). Falls and medications in the elderly. Nether-
lands Journal of Medicine, 63, 91-96.
Deshpande, N., Metter, E. J., Bandinelli, S., Lauretani, F., Windham, B. G., & Ferrucci, L. 
(2008a). Psychological, physical, and sensory correlates of fear of falling and 
consequent activity restriction in the elderly: The InCHIANTI study. American 
Journal of Physical Medicine and Rehabilitation, 87, 354-362.
Deshpande, N., Metter, E. J., Lauretani, F., Bandinelli, S., Guralnik, J., & Ferrucci, L. 
(2008b). Activity restriction induced by fear of falling and objective and subjec-
tive measures of physical function: A prospective cohort study. Journal of American 
Geriatrics Society, 56, 615-620.
Ensrud, K. E., Blackwell, T. L., Mangione, C. M., Bowman, P. J., Whooley, M. A., 
Bauer, D. C., . . . Nevitt, M. C. (2002). Central nervous system—active medica-
tions and risk for falls in older women. Journal of the American Geriatrics Soci-
ety, 50, 1629-1637.
Fletcher, P. C., Berg, K., Dalby, D. M., & Hirdes, J. P. (2009). Risk factors for falling 
among community-based seniors. Journal of Patient Safety, 5, 61-66.
Fletcher, P. C., Guthrie, D. M., Berg, K., & Hirdes, J. P. (2010). Risk factors for 
restriction in activity associated with fear of falling among seniors within the 
community. Journal of Patient Safety, 6, 187-191.
Fletcher, P. C., & Hirdes, J. P. (2004). Restriction in activity associated with fear of 
falling among community-based seniors using home care services. Age and Age-
ing, 33, 273-279.
French, D. D, Campbell, R., Spehar, A., & Angarn, D. M (2005). Benzodiazepines 
and injury: A risk adjusted model. Pharmacoepidemiology and Drug Safety, 14, 
17-24.
Fries, B. E., Simon, S. E., Morris, J. N., Flodstrom, C., & Bookstein, F. L. (2001). 
Pain in US nursing homes: Validating a pain scale for the Minimum Data Set. 
Gerontologist, 41, 173-179.
 at WILFRID LAURIER UNIV on October 26, 2011jah.sagepub.comDownloaded from 
Guthrie et al. 17
Hartikainen, S., Lonnroos, E., & Louhivuori, K. (2007). Medication as a risk factor 
for falls: Critical systematic review. Journal of Gerontology: Medical Sciences, 
62A, 1172-1181.
Hartmaier, S. L., Sloane, P. D., Guess, H. A., Koch, G. G., Mitchell, C. M., & Phillips, C. D. 
(1995). Validation of the Minimum Data Set Cognitive Performance Scale: Agree-
ment with the Mini-Mental State Examination. Journals of Gerontology.Series A, 
Biological Sciences and Medical Sciences, 50A, M128-M133.
Hirdes, J. P., Frijters, D. H., & Teare, G. F. (2003). The MDS-CHESS Scale: A new mea-
sure to predict mortality in institutionalized older people. Journal of the American 
Geriatrics Society, 51, 96-100.
Hosmer, D. W., & Lemeshow, S. (2000). Applied logistic regression (2nd ed.). Hoboken, 
NJ: John Wiley.
Jang, S. N., Cho, S. I., Oh, S. W., Lee, E. S., & Baik, H. W. (2007). Time since falling 
and fear of falling among community-dwelling elderly. International Psychogeri-
atric Association, 19, 1072-1083.
Kelly, K. D., Pickett, W., Yiannakoulias, N., Rowe, B. H., Schopflocher, D. P., 
Svenson, L., & Voaklander, D. C. (2003). Medication use and falls in community 
dwelling older persons. Age and Ageing, 32, 503-509.
Kempen, G. I., van Haastregt, J. C., McKee, K. J., Delbaere, K., & Zijlstra, G. A. 
(2009). Socio-demographic, health-related and psychosocial correlates of fear of 
falling and avoidance of activity in community-living older persons who avoid 
activity due to fear of falling. BMC Public Health, 2, 170.
Lawlor, D. A., Patel, R., & Ebrahim, S. (2003). Association between falls in elderly 
women and chronic diseases and drug use: Cross sectional study. British Medical 
Journal, 327, 712-717.
Leipzig, R. M., Cumming, R. G., & Tinetti, M. E. (1999). Drugs and falls in older 
people: A systematic review and meta-analysis: I. psychotropic drugs. Journal of 
the American Geriatrics Society, 47, 30-39.
Martin, L., Poss, J. W., Hirdes, J. P., Jones, R. N., Stones, M. J., & Fries, B. E. (2008). 
Predictors of a new depression diagnosis among older adults admitted to complex 
continuing care: Implications for the Depression Rating Scale (DRS). Age and 
Ageing, 37, 51-56.
Morris, J. N., Berg, K., Bjorkgren, M. A., Frijters, D., Fries, B. E., Gilgen, R., . . . 
Steel, K. (2006). InterRAI-Community Health Assessment (CHA). Guide for use of 
the interRAI CHA assessment form, Canadian version 07. Boston, MA: interRAI.
Morris, J. N., Fries, B. E., Bernabei, R., Steel, K., Ikegami, N., Carpenter, G. I.,. . . . 
Hirdes, J. P. (1999). RAI-Home Care (RAI-HC) assessment manual for Version 2.0. 
Washington, DC: interRAI.
 at WILFRID LAURIER UNIV on October 26, 2011jah.sagepub.comDownloaded from 
18  Journal of Aging and Health XX(X)
Morris, J. N., Fries, B. E., Mehr, D. R., Hawes, C., Mor, V., & Lipsitz, L (1994). MDS 
Cognitive Performance Scale. Journals of Gerontology.Series A, Biological Sci-
ences and Medical Sciences, 49, M174-M182.
Morris, J. N., Fries, B. E., & Morris, S. A. (1999). Scaling ADLs within the MDS. 
Journals of Gerontology.Series A, Biological Sciences and Medical Sciences, 
54A, M546-M553.
Muir, S. W., Berg, K., Chesworth, B., & Speechley, M. (2008). Use of the Berg Bal-
ance Scale for predicting multiple falls in community-dwelling elderly people: A 
prospective study. Physical Therapy, 88, 449-459.
Murphy, S. L., Williams, C. S., & Gill, T. M. (2002). Characteristics associated with 
fear of falling and activity restriction in community-living older persons. Journal 
of the American Geriatrics Society, 60, 516-520.
Richards, J. B, Papaioannou, A., Adachi, J. D, Joseph, L., Whitson, H. E, Prior, J. C., 
& Goltzman, D. (2007). Effect of selective serotonin reuptake inhibitors on the 
risk of fracture. Archives of Internal Medicine, 167, 188-194.
SAS Institute Inc. (2001). The SAS System for Windows [Computer software]. Cary, 
NC: Author.
Scheffer, A. C., Schuurmans, M. J., van Dijk, N., van der Hooft, T., & de Rooij, S. E. 
(2008). Fear of falling: Measurement strategy, prevalence, risk factors and conse-
quences among older persons. Age and Ageing, 37, 19-24.
Sgadari A, Lapane KL, Mor, V., Landi F, Bernabei, R., & Gambassi G (2000). Oxida-
tive and nonoxidative benzodiazepines and the risk of femur fracture. The system-
atic assessment of geriatric drug use via Epidemiology Study Group. Journal of 
Clinical Psychopharmacology, 20, 234-239.
Souchet, E., Lapeyre-Mestre, M., & Montastruc, J. L. (2005). Drug related falls: A 
study in the French Pharmacovigilance database. Pharmacoepidemiology and 
Drug Safety, 14, 11-16.
Wilson, M. G., Miller, D. K., Andresen E. M., Malmstrom T. K., Miller J. P., & 
Wolinsky F. D. (2005). Fear of falling and related activity restriction among 
middle-aged African Americans. Journal of Gerontology: Medical Sciences, 60A, 
355-360.
Zijlstra, G. A., van Haastregt, J. C., van Eijk, J. T., van Rossum, E., Stalenhoef, P. A., 
& Kempen, G. I. (2007). Prevalence and correlates of fear of falling, and associ-
ated avoidance of activity in the general population of community-living older 
people. Age and Ageing, 36, 304-309.
 at WILFRID LAURIER UNIV on October 26, 2011jah.sagepub.comDownloaded from 
